Зонд-4 4 мг/2 мл 2 мл раствор для инъекций

Țară: Kârgâzstan

Limbă: rusă

Sursă: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Ingredient activ:

Ондансетрон

Disponibil de la:

Zee Laboratories Limited

Codul ATC:

A04AA01

INN (nume internaţional):

Ondansetron

Dozare:

4 мг/2 мл 2 мл

Forma farmaceutică:

раствор для инъекций

Unități în pachet:

№10

Tip de prescriptie medicala:

по рецепту

Produs de:

Zee Laboratories Limited (Индия)

Zonă Terapeutică:

Противорвотный препарат центрального действия, блокирующий серотониновые рецепторы

Rezumat produs:

ПЖВЛС: нет

Data de autorizare:

2016-10-26

Caracteristicilor produsului

yTBEP)ItAATO
{enapra
nflulilottoffirrr
Mun
lxauropo:ona
,r./3r,
c
I4HCTPyKT\Vrfl
TIOMEAI,IUpIHCKOMyTIPI,IMEHEHIIIO
TIPETIAPATA
3OHA-4
Topronoe
Ha3BaHrre
3orra-4
Me;mgyuapoAHoe
HerrareHToBaHrroe
Ha3BaHne
OH4aucerpou
Jlenapc'rneHHafl
doprua
Pac'rnop
Arq
uHrexunfr.
Cocran
I
arruyra
coAepxlrr
.A.rcntue
u o
e
6
e
u,lr
e
c
m6
o
.'
OH4aucerpoHa
ruApoxnopul
lurlrApar
3KBr,rBaJreHTHo
oHAaHcerpouy
2
ur.
B
cnouozamen
bH
bte
6
etqe cm6
a
:
Flarpnr
xnoplu
-
18,0
Mr,
JrHMoFruElfi
xucrorbr
MoHorraApar
-
1
nr,
qurpar
Harpufl,
-
I
ur,
BoAir.qrrf,
uurexqufi
-
q.s.
Onucasue
flpo:pavusIfi
ro.IrI4
6ecuserH[,rfr
pacrnop,
3arroJrHeHHrrfi
s ilpo3par{Hbre
creKJr.f,HHbre
aMflynbr.
(Da
Jlnrarcorep
arr
eBTrrqecKaq
rpy[[
a
flporuropnorr{oe
cpercrBo
6lorarop-ceporoHrrHoBbrx
peqenropoB.
Koa
ATX
A04AA0I
()a
Jlrra
xororrrrrecKr,r
e
c
n
ofr
crea
3on,q-4
BbIcoKoceJIeKTI,IBHo
6.roxupyer
ueHTpanbHue
(xeuopeuenropbr
rpurrepHofi
3oHbr,
paorunft
ueurp)
u
nepu$epuqecKlle
ceporoHrrHonue
5-HT3-peqenroprr.
Blorupyr
5-HT3-
peuelropbl,
oHAaucerpoH
nperynpexAaer
Bo3Hr.rKHoBeHr.re
pBorHoro
peQnexca.
Kpoue roro,
oHAaHcerpoH
yrHeraer
ueHrpanbHbre
3BeHbfl
pBorHoro pe$:rexca,
6norupyr
5-HT3-peqerrropbr
lna
IV
xenyloqxa.
Ilpeuapar
npeAyflpexraer
vltu
ycrpaH{errorxHoryr4p{)Ty,
Bbr3BaHHbre
rlurocrarrr.recroft
(rro.qasrqrcuefi
AeneHHe
xreror),
[porrrBooflyxoreaofi
xr,rM]rorepaila]r
ulnln
lyrenofi
repanueii,
a
raKxe
B
nocneonepaqrroHHoM
rrepuoAe.
JlexapcrneuHbre
cpeAcrBaAn,
IlllTocrarfiqecxoft
xl{Ml4orepafluv
v
palrrorepalufl
Moryr
Bbr3Barb
noBbrrxeHr4e
ypoBHs
ceporoHr{Ha,
xoropufi
nyreM
aKTHBarIur4
BafycHbrx
a$Qep,eg111brx
BoJroKoH,
coAepxaulptx
5-
IlTr-
peuelropbl,
BbI3bIBaer
pnoruuil
peQrerc.
3ona-4.
TopM03r.{r iroqBreHr.re
pBorHoro
petf.:rercca
rlyreM
6noxa4rr
5-HT:-
peuerropoB
Ha
ypoBHe
neftpouon
xar
I{HC, raK
u
rrenrrrfi
enr,rtrecrrnri
rrenprrnri
^rrrr.FcrtrLr
3oua-4 He
uu4)t(aeT
ncuxouoropuofi
axTr,rBHocrr,r
[auueHTa,
He
Bbr3brBaeT
cenarr,rBHoro
eft{exra
}'t
He
cH}I)Kaer
pa6orocnoco6nocru.
He
Hapyuraer
KoopAr,rHarlurc
1uzxeuufi.
He
Ir3MeHfl
eT KOHUeHTpaUU}o
npon